Controlled release of nitric oxide for enhanced tumor drug delivery and reduction of thrombosis risk-Reference-Cited by-同舟云学术

Controlled release of nitric oxide for enhanced tumor drug delivery and reduction of thrombosis risk

Published:2022 Issue:50 Volume:12 Page:32355-32364
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Liu Rui¹,Xu Baofeng²,Ma Zhifang³,Ye Hongbo³,Guan Xinghua³,Ke Yue³⁴,Xiang Zehong³⁴,Shi Qiang³⁴^ORCID

Affiliation:

1. Department of VIP Unit, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130022, China

2. Stroke Center and Department of Neurology, First Hospital of Jilin University, Changchun, Jilin 130022, China

3. State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China

4. University of Science and Technology of China, Hefei, Anhui 230026, China

Abstract

Antiplatelet nanoparticles co-loaded with l-arginine (LA) and photosensitizer IR783 were established for local NO release to inhibit tumor-associated platelets activation, suppress thrombosis and increase tumoral accumulation of the nanoagent.

Funder

National Natural Science Foundation of China

Education Department of Jilin Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/RA/D2RA05438H

Reference43 articles.

1. Thrombosis and cancer

2. Mechanisms and biomarkers of cancer-associated thrombosis